Drug Profile
Research programme: small molecule therapeutics - Curadev Pharma
Alternative Names: CRD 1400Latest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Curadev Pharma
- Developer Curadev Pharma; Roche; University of Texas Southwestern Medical Center
- Class Anti-inflammatories; Antineoplastics; Small molecules
- Mechanism of Action Acetate-CoA ligase inhibitors; Coenzyme-A ligase inhibitors; Indoleamine-pyrrole 2,3-dioxygenase inhibitors; Phosphotransferase inhibitors; Transcription factor modulators; Tryptophan oxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Cancer; Glioblastoma; Haematological malignancies; Immunological disorders; Malignant melanoma; Solid tumours
Most Recent Events
- 28 May 2022 No recent reports of development identified for preclinical development in Cancer in India
- 28 Jan 2022 No recent reports of development identified for research development in Glioblastoma in India
- 28 Jan 2022 No recent reports of development identified for research development in Glioblastoma in USA